BDCRB
CAS No. 142356-43-2
BDCRB( GW 275175 )
Catalog No. M11787 CAS No. 142356-43-2
BDCRB (GW 275175) is a potent and selective inhibitor of human CMV replication by blocking the processing and maturation of viral DNA.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBDCRB
-
NoteResearch use only, not for human use.
-
Brief DescriptionBDCRB (GW 275175) is a potent and selective inhibitor of human CMV replication by blocking the processing and maturation of viral DNA.
-
DescriptionBDCRB (GW 275175) is a potent and selective inhibitor of human CMV replication by blocking the processing and maturation of viral DNA.
-
In Vitro——
-
In Vivo——
-
SynonymsGW 275175
-
PathwayMicrobiology/Virology
-
TargetCMV
-
RecptorCMV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number142356-43-2
-
Formula Weight398.034
-
Molecular FormulaC12H11BrCl2N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(2R,3R,4S,5R)-2-(2-bromo-5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Townsend LB, et al. J Med Chem. 1995 Sep 29;38(20):4098-105.
2. Underwood MR, et al. J Virol. 1998 Jan;72(1):717-25.
3. Nassiri MR, et al. Br J Haematol. 1996 May;93(2):273-9.
4. Williams SL, et al. Antimicrob Agents Chemother. 2003 Jul;47(7):2186-92.
molnova catalog
related products
-
Cidofovir
The prodrug of cidofovir diphosphate that inhibits cytomegalovirus (CMV) viral replication by selectively inhibiting viral DNA polymerases.
-
Brincidofovir
Brincidofovir (CMX 001;Cidofovir HDP) is a lipid conjugate of the acyclic nucleotide phosphonate.
-
CEF20
CEF20, a CEF control peptide pool, is an HLA-A*0201-restricted epitope from cytomegalovirus pp65 (495-503).
Cart
sales@molnova.com